Helen of Troy Limited (NASDAQ:HELE – Get Free Report) has received a consensus recommendation of “Hold” from the five brokerages that are covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a strong buy rating on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $22.00.
HELE has been the subject of a number of recent analyst reports. UBS Group decreased their price target on Helen of Troy from $25.00 to $22.00 and set a “neutral” rating for the company in a report on Friday, January 9th. Zacks Research downgraded Helen of Troy from a “hold” rating to a “strong sell” rating in a report on Tuesday, January 20th. Canaccord Genuity Group set a $22.00 price target on Helen of Troy in a report on Friday, January 9th. CJS Securities upgraded shares of Helen of Troy to a “strong-buy” rating in a research note on Thursday, December 11th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Helen of Troy in a research report on Monday, December 29th.
View Our Latest Research Report on Helen of Troy
Key Helen of Troy News
- Neutral Sentiment: High-profile backlash over casting Lupita Nyong’o as Helen of Troy — Elon Musk publicly criticized Christopher Nolan’s casting choice and threatened a boycott, sparking wide media pickup. Elon Musk Attacks Christopher Nolan for Casting Lupita Nyong’o as Helen of Troy in The Oddysey
- Neutral Sentiment: Conservative media amplification — a Newsmax host echoed complaints about “forced diversity” in casting, adding to the social-media and cable coverage. Newsmax host complains about Lupita Nyong’o playing Helen Troy
- Neutral Sentiment: Widespread repetition across outlets — multiple entertainment and general news sites ran variations of the story, keeping it in public view but not tied to Helen of Troy (HELE) the company. Elon Musk Rips Odyssey Over Race Controversy
Institutional Trading of Helen of Troy
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Pzena Investment Management LLC boosted its holdings in Helen of Troy by 2.6% in the third quarter. Pzena Investment Management LLC now owns 1,010,756 shares of the company’s stock worth $25,471,000 after acquiring an additional 25,425 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Helen of Troy by 159.2% during the third quarter. Wellington Management Group LLP now owns 747,220 shares of the company’s stock valued at $18,830,000 after acquiring an additional 458,979 shares in the last quarter. Ameriprise Financial Inc. raised its position in shares of Helen of Troy by 46.4% during the third quarter. Ameriprise Financial Inc. now owns 658,928 shares of the company’s stock worth $16,605,000 after purchasing an additional 208,850 shares during the period. UBS Group AG lifted its holdings in shares of Helen of Troy by 386.0% in the 4th quarter. UBS Group AG now owns 616,992 shares of the company’s stock worth $13,111,000 after purchasing an additional 490,031 shares in the last quarter. Finally, Invenomic Capital Management LP grew its position in Helen of Troy by 68.8% in the 3rd quarter. Invenomic Capital Management LP now owns 554,985 shares of the company’s stock valued at $13,986,000 after purchasing an additional 226,263 shares during the period.
Helen of Troy Price Performance
Shares of HELE opened at $17.34 on Wednesday. The business has a 50-day moving average of $19.75 and a 200-day moving average of $21.34. The company has a debt-to-equity ratio of 1.02, a current ratio of 1.81 and a quick ratio of 0.90. The company has a market capitalization of $400.03 million, a price-to-earnings ratio of -0.50 and a beta of 0.81. Helen of Troy has a 1 year low of $16.29 and a 1 year high of $60.42.
Helen of Troy (NASDAQ:HELE – Get Free Report) last released its earnings results on Thursday, January 8th. The company reported $1.71 earnings per share for the quarter, missing analysts’ consensus estimates of $1.75 by ($0.04). The firm had revenue of $512.83 million for the quarter, compared to analyst estimates of $502.42 million. Helen of Troy had a negative net margin of 43.97% and a positive return on equity of 8.33%. The business’s revenue for the quarter was down 3.4% compared to the same quarter last year. During the same period in the prior year, the company posted $2.67 EPS. Helen of Troy has set its FY 2026 guidance at 3.250-3.75 EPS and its Q4 2026 guidance at 0.530-1.030 EPS. As a group, equities research analysts anticipate that Helen of Troy will post 6.46 earnings per share for the current year.
About Helen of Troy
Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.
The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.
See Also
- Five stocks we like better than Helen of Troy
- Your Bank Account Is No Longer Safe
- Ray Dalio Says Buy Gold. I Say Get Paid Every Month From It
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
- They just tried to kill gold
Receive News & Ratings for Helen of Troy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helen of Troy and related companies with MarketBeat.com's FREE daily email newsletter.
